1. AtraZeneca to co-develop Parkinson’s drug with Takeda in $400M deal
AstraZeneca will partner with Takeda Pharmaceuticals to co-develop an experimental drug to treat Parkinson’s disease.
2. Why this drug study could redefine heart disease treatment
Reducing inflammation — independent of lowering cholesterol — can reduce the risk of heart attacks, according to research sponsored by Novartis and presented Aug. 27 at the European Society of Cardiology in Barcelona.
3. FDA grants MDMA breakthrough status for treatment of PTSD: 4 things to know
The Food and Drug Administration in August granted breakthrough designation to a Santa Cruz, Calif.-based nonprofit’s MDMA therapy for post-traumatic stress disorder.
4. Novartis, CMS collaborate on outcomes-based pricing for $475k leukemia drug
Novartis will partner with CMS to offer an outcomes-based pricing model for its new leukemia drug Kymriah.
5. Trump adviser backs offshore testing of herpes vaccine that evaded US safety protocols
A group of wealthy businessmen, including Trump adviser Peter Thiel, are backing Rational Vaccines’ offshore testing of an experimental herpes vaccine that bypassed U.S. safety protocols for human clinical trials.
6. Novartis CEO to step down, hand over duties to drug development chief: 5 notes
Novartis, a Swiss pharmaceutical company, named its Global Head of Drug Development and CMO Vasant Narasimhan, MD, successor to current CEO Joe Jimenez, who will step down Jan. 31.
More articles on supply chain:
McKesson donates $150k worth of medical supplies to Hurricane Harvey relief efforts
Teleflex to acquire NeoTract for up to $1.1B
6 FDA decisions to look for in September
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
